Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 157

1.

Age-related differences in patterns of increased Bordetella pertussis antibodies.

Prince HE, Lieberman JM, Cherry JD.

Clin Vaccine Immunol. 2012 Apr;19(4):545-50. doi: 10.1128/CVI.05725-11.

2.
3.

Evaluation of a tetraplex microsphere assay for Bordetella pertussis antibodies.

Prince HE, Lapé-Nixon M, Matud J.

Clin Vaccine Immunol. 2006 Feb;13(2):266-70.

4.

Response and decline of serum IgG antibodies to pertussis toxin, filamentous hemagglutinin and pertactin in children with pertussis.

Isacson J, Trollfors B, Hedvall G, Taranger J, Zackrisson G.

Scand J Infect Dis. 1995;27(3):273-7.

PMID:
8539553
5.

Comparison of Western immunobloting to an enzyme-linked immunosorbent assay for the determination of anti-Bordetella pertussis antibodies.

Merrigan SD, Welch RJ, Litwin CM.

Clin Vaccine Immunol. 2011 Apr;18(4):615-20. doi: 10.1128/CVI.00450-10.

6.

Stability of antibodies to Bordetella antigens in German adults.

Saemann-Ischenko G, Tillmanns B, Kösters K, Riffelmann M, Wirsing von König CH.

Eur J Clin Microbiol Infect Dis. 2001 Dec;20(12):850-3.

PMID:
11837635
7.

Serum IgG antibody responses to pertussis toxin and filamentous hemagglutinin in nonvaccinated and vaccinated children and adults with pertussis.

Trollfors B, Taranger J, Lagergård T, Sundh V, Bryla DA, Schneerson R, Robbins JB.

Clin Infect Dis. 1999 Mar;28(3):552-9.

PMID:
10194077
8.

Distribution of pertussis antibodies among different age groups in Japan.

Konda T, Kamachi K, Iwaki M, Matsunaga Y.

Vaccine. 2002 Mar 15;20(13-14):1711-7.

PMID:
11906757
9.

Prospective evaluation of an Australian pertussis toxin IgG and IgA enzyme immunoassay.

May ML, Doi SA, King D, Evans J, Robson JM.

Clin Vaccine Immunol. 2012 Feb;19(2):190-7. doi: 10.1128/CVI.05430-11.

10.

Immunization of teenagers with a fifth dose of reduced DTaP-IPV induces high levels of pertussis antibodies with a significant increase in opsonophagocytic activity.

Aase A, Herstad TK, Merino S, Bolstad M, Sandbu S, Bakke H, Aaberge IS.

Clin Vaccine Immunol. 2011 Aug;18(8):1269-74. doi: 10.1128/CVI.05067-11.

11.

Evaluation of serologic assays for diagnosis of whooping cough.

Granström G, Wretlind B, Salenstedt CR, Granström M.

J Clin Microbiol. 1988 Sep;26(9):1818-23.

12.

The seroepidemiology of Bordetella pertussis infections: a study of persons ages 1-65 years.

Cattaneo LA, Reed GW, Haase DH, Wills MJ, Edwards KM.

J Infect Dis. 1996 May;173(5):1256-9.

PMID:
8627081
13.

Long-term immunogenicity of a single dose of acellular pertussis vaccine in paediatric health-care workers.

Littmann M, Hülsse C, Riffelmann M, Wirsing von König CH.

Vaccine. 2008 May 2;26(19):2344-9. doi: 10.1016/j.vaccine.2008.02.065.

PMID:
18396360
14.

Prevalence of pertussis antibodies in maternal delivery, cord, and infant serum.

Healy CM, Munoz FM, Rench MA, Halasa NB, Edwards KM, Baker CJ.

J Infect Dis. 2004 Jul 15;190(2):335-40.

PMID:
15216470
16.

Immunoglobulin A antibodies to pertussis toxin and filamentous hemagglutinin in saliva from patients with pertussis.

Zackrisson G, Lagergård T, Trollfors B, Krantz I.

J Clin Microbiol. 1990 Jul;28(7):1502-5.

19.

Sero epidemiology of Bordetella pertussis immune responses in a healthy population in northern Greece.

Polyzou A, Pournaras S, Dafni U, Sofianou D, Christeli E, Patrinos S, Tsakris A.

J Clin Lab Anal. 2004;18(3):211-4.

PMID:
15103688
20.

Antibodies to pertussis antigens in pediatric health care workers.

Riffelmann M, Koesters K, Saemann-Ischenko G, Schmitt HJ, Wirsing von Koenig CH.

Pediatr Infect Dis J. 2002 May;21(5):381-3.

PMID:
12150172

Supplemental Content

Support Center